Q&A on hepatitis C epidemic in Appalachian states

June 8, 2015 by Joseph Sullivan, University of Massachusetts Dartmouth
Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.

A recent study released by the Centers for Disease Control and Prevention (CDC) found that hepatitis C cases across four Appalachian states—Kentucky, Tennessee, West Virginia, and Virginia—more than tripled between 2006 and 2012. The study is the first from the CDC to link the rise in hepatitis C to an increase in injection drug use and raises concern that a single person could become the "Typhoid Mary of HIV."

UMass Law Associate Professor Margaret Drew, Director of Clinics and Experiential Learning at the Law School, has been named a Bellow Scholar by the Association of American Law Schools (AALS) and received a research award to support a cross-college project that will assess the unmet legal, medical and other needs of HIV-positive individuals living in the SouthCoast region in Massachusetts.

"Building Community Capacity for HIV-Positive Individuals in SouthCoast, Massachusetts" is the project for which Margaret received the fellowship. The research also received $32,000 through the University of Massachusetts President's Creative Economy Initiatives Fund to establish multi-disciplined community partnerships to reduce physical, social, healthcare, and legal barriers for HIV-positive individuals living in New Bedford and Fall River; and to contribute to the workforce development of community health workers in the SouthCoast region. The project is a partnership between Dr. Caitlin Stover of UMass Dartmouth's College of Nursing and UMass Law Lecturer Jason Potter Burda.

Professors Drew, Burda, and Stover discuss the CDC report and spillover issues (legal, medical, etc.) that these states and the communities within them are experiencing.

According to a new report issued by the U.S. Centers for Disease Control and Prevention Hepititis C infections rose 364 percent from 2006 to 2012 in Kentucky, Tennessee, Virginia and West Virginia. How surprising should we be by this substantial increase?

MD: We should not be surprised by these findings. Those living in rural areas and in poverty would have the most difficulty in obtaining adequate assistance with the resulting mental and physical health needs that addiction brings. The southern states have had higher rates of infection of both Hep-C and HIV than other regions. But Hep-C and HIV infections are increasing all over the country, primarily due the increase in use. The SouthCoast is experiencing significant increases in infections of Hep-C and HIV (frequently these are concurrent diagnoses) which is why our team decided to focus our research in this area. We will be assessing the unmet legal, health and other needs of those living with HIV. We expect that many of the HIV+ individuals we interview will also be living with Hep C.

How significant is it that this report is the first CDC study to link the rise in hepatitis C to an increase in injection drug use?

CS: I think that this is notable because the CDC is starting to recognize that use is not responding to public health education efforts as it continues to be on the rise, especially in urbanized cities. Instead of turning away from it, the CDC it is acknowledging the problem both in rural and urban areas. This will ultimately help in reducing the stigma faced by the intravenous drug use (IDU) population. Once society can reduce the stigma (both actual and perceived), the real work of reducing Hepatitis C and other diseases transmitted via IDU can begin.

What are the spillover issues (legal, medical, etc.) that these states and the communities within them are experiencing?

JPB: One of the medical and attendant policy-related issues is that the Hepatitis C virus (HCV) itself, unlike HIV, sustains its viability long after it is exposed to air. For example, HCV can survive on a used syringe for months after injection depending on the conditions. This puts into perspective the necessity of safe syringe disposal and clean syringe access. Nonetheless, successful harm reduction programs, such as syringe exchanges staffed by community health workers trained to link addicts to additional treatment, are unable to seek federal funding due to the federal ban on funding for needle exchange programs. So, states wishing to operate these services must fund the programs themselves or seek the help of private organizations. Access to successful treatment of Hep-C is a barrier to those who are uninsured or inadequately insured. Because of the connection between poverty and Hep-C and HIV, our research may uncover links between the infectious diseases and inadequate housing conditions, difficulties in accessing benefits, as well as discrimination due to stigma.

Explore further: Why are HIV survival rates lower in the Deep South than the rest of the US?

Related Stories

Why are HIV survival rates lower in the Deep South than the rest of the US?

April 22, 2015
The Deep South region has become the epicenter of the US HIV epidemic. Despite having only 28% of the total US population, nine states in the Deep South account for nearly 40% of national HIV diagnoses. This region has the ...

Indiana HIV outbreak, hepatitis C epidemic sparks US alert

April 24, 2015
Federal health officials helping to contain an HIV outbreak in Indiana state issued an alert to health departments across the U.S. on Friday, urging them to take steps to identify and track HIV and hepatitis C cases in an ...

Appalachia gripped by hepatitis C epidemic, bracing for HIV

June 4, 2015
Patton Couch shook his head and clenched his teeth, recounting the night four years ago when he plucked a dirty needle from a pile at a flophouse and jabbed it into his scarred arm.

Risk of hepatitis D higher among HIV infected and injection drug users

April 21, 2015
Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country. ...

HIV cases skyrocket among US painkiller abusers (Update)

April 24, 2015
Cases of HIV have skyrocketed among injection drug users in a rural community in the midwestern state of Indiana where 142 people have been diagnosed since the beginning of the year, officials said Friday.

Indiana allows needle exchange program to stem HIV outbreak

March 26, 2015
Indiana's governor authorized a short-term needle-exchange program and other steps Thursday to help contain the spread of HIV in a county tied to 79 new infections since January, all of them linked to intravenous drug use.

Recommended for you

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

Dengue takes low and slow approach to replication

January 11, 2018
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure ...

Different strains of same bacteria trigger widely varying immune responses

January 11, 2018
Genetic differences between different strains of the same pathogenic bacterial species appear to result in widely varying immune system responses, according to new research published in PLOS Pathogens.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.